Vivimed Labs Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 414.62 million compared to INR 557.4 million a year ago. Revenue was INR 415.01 million compared to INR 557.93 million a year ago. Net loss was INR 160.49 million compared to INR 183.12 million a year ago. Basic loss per share from continuing operations was INR 1.94 compared to INR 2.21 a year ago. Diluted loss per share from continuing operations was INR 1.88 compared to INR 2.14 a year ago.
For the nine months, sales was INR 1,104.55 million compared to INR 1,500.69 million a year ago. Revenue was INR 1,128.07 million compared to INR 1,503.54 million a year ago. Net loss was INR 507.08 million compared to INR 625.46 million a year ago. Basic loss per share from continuing operations was INR 6.12 compared to INR 7.54 a year ago. Diluted loss per share from continuing operations was INR 5.94 compared to INR 7.32 a year ago.